GVEYX
Price
$18.60
Change
-$0.52 (-2.72%)
Updated
Dec 18 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

GVEYX vs RMFCX

Header iconGVEYX vs RMFCX Comparison
Open Charts GVEYX vs RMFCXBanner chart's image
GuideStone Funds Value Equity Instl
Price$18.60
Change-$0.52 (-2.72%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
GVEYX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVEYX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVEYX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. GVEYX (1.09B). RMFCX pays higher dividends than GVEYX: RMFCX (1.69) vs GVEYX (1.35). GVEYX was incepted earlier than RMFCX: GVEYX (23 years) vs RMFCX (23 years). GVEYX is a more actively managed with annual turnover of: 38.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than GVEYX: RMFCX (250) vs GVEYX (1000000). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. GVEYX (9.67). RMFCX return over 5 years is better than : 40.39 vs. GVEYX (8.25).
GVEYXRMFCXGVEYX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD8.87211.42378%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.09B104B1%
Annual Yield % from dividends1.351.6980%
Returns for 1 year9.6712.6377%
Returns for 3 years-3.7814.16-27%
Returns for 5 years8.2540.3920%
Returns for 10 years-4.3361.84-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc